{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:14Z","timestamp":1788922214107,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-00277-24-00"],"award-info":[{"award-number":["075-00277-24-00"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejmech.2024.117189","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:27:28Z","timestamp":1734539248000},"page":"117189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Orvinol-based opioid receptor antagonist fluorinated at C(20)-pharmacophore"],"prefix":"10.1016","volume":"284","author":[{"given":"A.A.","family":"Ambartsumyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.V.","family":"Belozertseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.\u0410.","family":"Dravolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.E.","family":"Zvartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.V.","family":"Sandulenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Zelentsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Peregudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-8725","authenticated-orcid":false,"given":"S.K.","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117189_bib1","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/molecules27092863","article-title":"Diels-Alder adducts of morphinan-6,8-dienes and their transformations","volume":"27","author":"Marton","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117189_bib2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1021\/jm021118o","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. 18.1 N-Substituted 14-Phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships","volume":"46","author":"Greiner","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112145","article-title":"Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivatives","volume":"191","author":"Sz\u0171cs","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2024.117189_bib5","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Application of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/acs.chemrev.5b00392","article-title":"Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas","volume":"116","author":"Zhou","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117189_bib7","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib8","series-title":"Bioorganic and Medicinal Chemistry of Fluorine","author":"Begue","year":"2008"},{"key":"10.1016\/j.ejmech.2024.117189_bib9","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.bmcl.2005.07.025","article-title":"Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand","volume":"15","author":"Betageri","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117189_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bmcl.2012.10.100","article-title":"The effect of 17-N substituents on the activity of the opioid \u03ba receptor in nalfurafine derivatives","volume":"23","author":"Nemoto","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117189_bib11","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1016\/j.bmc.2013.10.032","article-title":"The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, \u03b4 opioid receptor agonists","volume":"21","author":"Nemoto","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib12","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bmcl.2015.05.038","article-title":"Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as \u03b4 opioid receptor inverse agonists","volume":"25","author":"Nemoto","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117189_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2021.138723","article-title":"Computational design of \u03b2-fluorinated morphine derivatives for pH-specific binding","volume":"777","author":"Alexander","year":"2021","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejmech.2024.117189_bib14","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1039\/D0OB00619J","article-title":"Fluorinated and [18F]fluorinated morphinan based opioid ligands","volume":"18","author":"Sandulenko","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1039\/D2OB02144G","article-title":"Control of the diastereoselectivity at C(20) in the formation of C(21)-fluorinated thevinols","volume":"21","author":"Sandulenko","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115296","article-title":"\u0421-21-Fluorinated thevinol scaffold for opioid ligands. 21,21,21-Trifluoro-6-O-nororvinols: design, synthesis and analgesic activity","volume":"252","author":"Sandulenko","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib17","first-page":"2569","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. Part XVI. Some derivatives of 6,14-endo-etheno-7,8-dihydromorphine","author":"Bentley","year":"1969","journal-title":"J. Chem. Soc. (C)"},{"key":"10.1016\/j.ejmech.2024.117189_bib18","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1021\/jm030878b","article-title":"Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-Phenylpropoxymetopon: an extremely powerful analgesic","volume":"46","author":"Sch\u00fctz","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib19","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1039\/D1NR03084A","article-title":"Membrane-selective nanoscale pores in liposomes by a synthetically evolved peptide: implications for triggered release","volume":"13","author":"Sun","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2024.117189_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/jm00297a041","article-title":"Novel analgetics and molecular rearrangements in the morphine-thebaine group. XVIII. 3-Deoxy-6,14-endo-etheno-6,7,8,14-tetrahydrooripavines","volume":"13","author":"Lewis","year":"1970","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib21","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/ja00989a032","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine","volume":"89","author":"Bentley","year":"1967","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117189_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-2952(66)90117-1","article-title":"Inhibition of cholinesterases by complex derivatives of morphine","volume":"15","author":"Lane","year":"1966","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117189_bib23","series-title":"Novel Derivatives of Thebaine and Oripavine, Great Britain Patent GB 969263","author":"Bentley","year":"1964"},{"key":"10.1016\/j.ejmech.2024.117189_bib24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/BF00813809","article-title":"Herstellung von 6,14- ethenomorphinan-derivaten","volume":"125","author":"Marton","year":"1994","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib25","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1039\/D3OB01577G","article-title":"C(21)-Di- and monofluorinated scaffold for thevinol\/orvinol-based opioid receptor ligands","volume":"21","author":"Zelentsova","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.117189_bib26","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja00989a031","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaine","volume":"89","author":"Bentley","year":"1967","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117189_bib27","series-title":"Manual on the Use of Laboratory Animals for Research and Training Purposes in Pavlov First Saint Petersburg State Medical University","first-page":"79","author":"Belozertseva","year":"2014"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424010717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:23:14Z","timestamp":1751386994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424010717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"alternative-id":["S0223523424010717"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117189","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orvinol-based opioid receptor antagonist fluorinated at C(20)-pharmacophore","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117189"}}